Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,701 | 388 | 99.8% |
| Education | $8.62 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $920.57 | 62 | $0 (2024) |
| Amgen Inc. | $608.21 | 47 | $0 (2024) |
| PFIZER INC. | $552.07 | 41 | $0 (2024) |
| Astellas Pharma US Inc | $360.20 | 20 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $325.54 | 23 | $0 (2024) |
| ABBVIE INC. | $244.08 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $217.44 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $212.85 | 16 | $0 (2024) |
| Abbott Laboratories | $211.57 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $169.99 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $776.22 | 46 | Novo Nordisk Inc ($178.36) |
| 2023 | $943.94 | 48 | Novo Nordisk Inc ($212.09) |
| 2022 | $849.49 | 56 | Novo Nordisk Inc ($200.43) |
| 2021 | $730.68 | 52 | Novo Nordisk Inc ($154.65) |
| 2020 | $334.76 | 22 | Allergan, Inc. ($52.34) |
| 2019 | $671.95 | 46 | Astellas Pharma US Inc ($213.77) |
| 2018 | $701.94 | 57 | Novo Nordisk Inc ($130.67) |
| 2017 | $700.59 | 62 | PFIZER INC. ($108.91) |
All Payment Transactions
389 individual payment records from CMS Open Payments — Page 2 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: VACCINES | ||||||
| 04/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.40 | General |
| Category: Cardiovascular | ||||||
| 03/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: Inflammation | ||||||
| 03/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Obesity | ||||||
| 03/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Bone Health | ||||||
| 03/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: Cardiology | ||||||
| 03/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Transcatheter Heart Valves | ||||||
| 02/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Inflammation | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Respiratory | ||||||
| 02/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: PSYCHIATRY | ||||||
| 02/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Obesity | ||||||
| 01/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Endocrinology | ||||||
| 01/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: UROLOGY | ||||||
| 01/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: Cardiology | ||||||
| 01/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: VACCINES | ||||||
| 12/05/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Bone Health | ||||||
| 11/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 62 | 7,380 | 11,158 | $1.2M | $301,542 |
| 2022 | 65 | 7,649 | 11,872 | $1.2M | $325,555 |
| 2021 | 67 | 8,057 | 12,679 | $1.3M | $357,115 |
| 2020 | 67 | 8,282 | 10,628 | $1.1M | $261,930 |
All Medicare Procedures & Services
261 procedure records from CMS Medicare Utilization — Page 3 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 80076 | Liver function blood test panel | Office | 2023 | 28 | 33 | $2,640 | $256.32 | 9.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 25 | 33 | $1,485 | $209.22 | 14.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 13 | 13 | $1,690 | $198.22 | 11.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 20 | 21 | $630.00 | $195.96 | 31.1% |
| 83540 | Iron level | Office | 2023 | 25 | 30 | $1,710 | $190.20 | 11.1% |
| 82310 | Calcium level, total | Office | 2023 | 25 | 31 | $930.00 | $156.86 | 16.9% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 28 | 36 | $1,188 | $150.48 | 12.7% |
| 82950 | Blood glucose (sugar) level after receiving dose of glucose | Office | 2023 | 27 | 30 | $1,080 | $139.50 | 12.9% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2023 | 25 | 33 | $957.00 | $122.76 | 12.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 17 | 28 | $1,064 | $117.60 | 11.1% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 13 | 13 | $260.00 | $95.93 | 36.9% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 11 | 20 | $460.00 | $46.40 | 10.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 372 | 372 | $51,328 | $45,779 | 89.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 430 | 557 | $105,273 | $42,933 | 40.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 116 | 1,132 | $113,200 | $38,665 | 34.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 115 | 954 | $104,940 | $33,528 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 290 | 499 | $62,375 | $28,392 | 45.5% |
| 77067 | Screening mammography | Office | 2022 | 120 | 120 | $48,075 | $9,766 | 20.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 138 | 145 | $13,080 | $9,667 | 73.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 64 | 323 | $27,455 | $9,485 | 34.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 435 | 675 | $76,275 | $8,837 | 11.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 29 | 29 | $11,600 | $7,723 | 66.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 405 | 482 | $81,980 | $6,886 | 8.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 331 | 396 | $48,708 | $6,567 | 13.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 437 | 572 | $50,336 | $5,958 | 11.8% |
About Dr. Norman Stevens, M.D
Dr. Norman Stevens, M.D is a Internal Medicine healthcare provider based in Macon, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679544001.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Norman Stevens, M.D has received a total of $5,710 in payments from pharmaceutical and medical device companies, with $776.22 received in 2024. These payments were reported across 389 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,701).
As a Medicare-enrolled provider, Stevens has provided services to 31,368 Medicare beneficiaries, totaling 46,337 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 261 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Macon, GA
- Active Since 02/01/2006
- Last Updated 12/15/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679544001
Products in Payments
- Ozempic (Drug) $364.01
- MYRBETRIQ (Drug) $346.66
- FARXIGA (Drug) $256.76
- XIFAXAN (Drug) $222.23
- ELIQUIS (Drug) $218.19
- Rybelsus (Drug) $216.03
- ENTRESTO (Drug) $174.02
- Otezla (Drug) $167.34
- MITRACLIP (Device) $164.40
- Prolia (Biological) $145.46
- SHINGRIX (Biological) $145.29
- PREVNAR 20 (Biological) $136.09
- Wegovy (Drug) $131.17
- Repatha (Biological) $129.07
- APLENZIN (Drug) $122.90
- XARELTO (Drug) $118.64
- NURTEC ODT (Drug) $115.47
- UBRELVY (Drug) $114.98
- JARDIANCE (Drug) $111.82
- GEMTESA (Drug) $110.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Macon
Sagar Panse, M.d, M.D
Internal Medicine — Payments: $784,712
Quyen Luu, Md, MD
Internal Medicine — Payments: $54,100
Lesley Cown, M.d., L.l.c, M.D., L.L.C
Internal Medicine — Payments: $39,643
Jonathan Brock, M.d, M.D
Internal Medicine — Payments: $31,696
Dr. Ahmad Kabbani, Md, MD
Internal Medicine — Payments: $15,693
Dr. Alan Justice, M.d, M.D
Internal Medicine — Payments: $14,983